Antimicrobial resistance (AMR) is a threat to our way of life. At the moment, it kills over 700,000 people each year globally (O’Neill 2016). However, it is the future threat that is truly existential: some estimates suggest that as many as 50 million people could die due to AMR each year by 2050 (O’Neill 2016). Innovation and development are the key to preventing this catastrophe.